Overexpression or gain of function mutations of c‐KIT has been reported in various cancers, such as gastrointestinal stromal tumors (GISTs), small‐cell lung carcinomas (SCLC), advanced systemic mastocytosis, and acute myeloid leukemia (AML).74 The gene discussed is KIT; the disease is acute myeloid leukemia.